Epstein-Barr Virus (EBV-gp125 VCA) Antigen

This recombinant antigen preparation presents the gp125 viral capsid component of Epstein-Barr Virus in a liquid, ready-to-use format for serological and immunological assays. The gp125 protein is a structural constituent of the EBV capsid that is abundantly expressed during lytic viral replication, and it serves as a well-established target for antibody-based detection of EBV exposure.

Provided at research scale in a 25 ml liquid volume by Antibodies.com, the reagent supports ELISA and Western blot workflows investigating EBV-associated conditions such as infectious mononucleosis, Burkitt lymphoma, nasopharyngeal carcinoma, and post-transplant lymphoproliferative disorder. The liquid format simplifies dilution and direct incorporation into plate-based or membrane-based immunoassays.

Beyond clinical diagnostics, the antigen is also a useful tool for vaccine research, immune monitoring studies, and characterization of monoclonal antibodies raised against EBV structural proteins. The 25 ml pack size accommodates high-throughput screening, longitudinal cohort studies, and quality control testing.